Yoneda F, Nakajima M, Kagawa S, Kurokawa K
Hinyokika Kiyo. 1985 Apr;31(4):585-94.
One hundred and thirty-two patients with renal cell carcinoma, treated by the TEKK Group, during the period from 1962 to 1983 were clinically reviewed. The patients ranged in age from 13 to 77 years with a mean age of 57.3 years, and were 89 men and 44 women, with a sex ratio of 2.07 to 1. The most common symptom was hematuria (55.4%), followed by palpable mass (19.2%), pain (13.8%) and fever (6.9%). The distant metastasis was observed in 26 patients (19.7%), mostly in the lung (54%) and the bone (19%). Overall estimated survival rates at 1,3 and 5 year were 83.0%, 58.2% and 56.9% respectively. The prognosis of the patients with renal cell carcinoma was dependent upon affected site, age, ESR, CRP, alpha 2-globulin and distant metastasis.
对1962年至1983年期间由TEKK集团治疗的132例肾细胞癌患者进行了临床回顾。患者年龄在13岁至77岁之间，平均年龄为57.3岁，其中男性89例，女性44例，性别比为2.07比1。最常见的症状是血尿（55.4%），其次是可触及肿块（19.2%）、疼痛（13.8%）和发热（6.9%）。26例患者（19.7%）出现远处转移，主要发生在肺部（54%）和骨骼（19%）。1年、3年和5年的总体估计生存率分别为83.0%、58.2%和56.9%。肾细胞癌患者的预后取决于受累部位、年龄、血沉、C反应蛋白、α2球蛋白和远处转移情况。
